TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 334 filers reported holding TANDEM DIABETES CARE INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,328,320 | -6.6% | 51,798 | -0.5% | 0.00% | -50.0% |
Q3 2022 | $2,492,219 | -21.4% | 52,084 | -2.8% | 0.00% | 0.0% |
Q2 2022 | $3,171,519 | -49.1% | 53,582 | +0.0% | 0.00% | -50.0% |
Q1 2022 | $6,230,702 | -42.3% | 53,579 | -25.3% | 0.00% | -42.9% |
Q4 2021 | $10,794,000 | +24.7% | 71,710 | -1.1% | 0.01% | 0.0% |
Q3 2021 | $8,659,000 | +280.8% | 72,529 | +105.3% | 0.01% | +133.3% |
Q1 2020 | $2,274,000 | +14.0% | 35,332 | +5.6% | 0.00% | +50.0% |
Q4 2019 | $1,994,000 | -0.9% | 33,456 | -2.2% | 0.00% | 0.0% |
Q3 2019 | $2,012,000 | -8.4% | 34,209 | +0.5% | 0.00% | -33.3% |
Q2 2019 | $2,196,000 | +4.8% | 34,038 | +3.1% | 0.00% | +50.0% |
Q1 2019 | $2,096,000 | +79.8% | 33,011 | +7.5% | 0.00% | +100.0% |
Q4 2018 | $1,166,000 | -16.1% | 30,709 | -5.4% | 0.00% | 0.0% |
Q3 2018 | $1,390,000 | +97.4% | 32,451 | +1.4% | 0.00% | 0.0% |
Q2 2018 | $704,000 | – | 31,990 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 1,000,000 | $59,610,000 | 47.04% |
Prospect Capital Advisors, LLC | 127,900 | $7,624,000 | 4.68% |
Asymmetry Capital Management, L.P. | 43,559 | $2,597,000 | 4.66% |
Copernicus Capital Management, LLC | 50,000 | $2,981,000 | 3.91% |
SECTORAL ASSET MANAGEMENT INC | 341,714 | $20,370,000 | 3.04% |
FRIESS ASSOCIATES LLC | 627,225 | $37,389,000 | 2.60% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,361,345 | $81,150,000 | 2.59% |
Parkman Healthcare Partners LLC | 134,959 | $8,045,000 | 2.32% |
OBERWEIS ASSET MANAGEMENT INC/ | 109,940 | $6,554,000 | 2.18% |
First Light Asset Management, LLC | 268,574 | $16,010,000 | 2.05% |